Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 4 Weeks

19-May-17 - 15-Jun-17
Buy Ratio:30%

Down

# Net Buyers:32
# Net Sellers:74

Previous 4 Weeks

21-Apr-17 - 18-May-17
Buy Ratio:37%
# Net Buyers:49
# Net Sellers:82
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals Inc$31.89M$33.24M  
Alnylam Pharmaceuticals, Inc.$21.28M$24.78M  
Exelixis, Inc.($92.30K)$13.07M  
Corium International, Inc.$11.89M$11.89M  
Vertex Pharmaceuticals Inc / Ma($13.91M)$10.35M  
New Net Buyers
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals Inc$31.89M$33.24M  
Alnylam Pharmaceuticals, Inc.$21.28M$24.78M  
Eagle Pharmaceuticals, Inc.$20.32K$4.79M  
Depomed Inc$148.80K$1.42M  
Xenon Pharmaceuticals Inc.$845.43K$851.06K  
Largest Negative Net Change
CompanyNet Buy AmountChange
Agios Pharmaceuticals Inc($347.68K)($31.11M)  
Biogen Inc.($466.37K)($18.39M)  
Steadymed Ltd.--($9.89M)  
Abbvie Inc.($14.90M)($9.51M)  
Opko Health, Inc.$5.56M($5.03M)  
New Net Sellers
CompanyNet Buy AmountChange
Agios Pharmaceuticals Inc($347.68K)($31.11M)  
Biogen Inc.($466.37K)($18.39M)  
Valeant Pharmaceuticals International, Inc.($77.05K)($249.03K)